And further western blotting examination of Vimentin, the EMT biomarker, in CRABP2 OE transfected EC109 cells in vitro and in vivo demonstrated that CRABP2 exerted its functions in cell metastasis by regulating EMT process in ESCC. Here, VIM is linked to esophageal squamous cell carcinoma.